Voriconazole: A Viewpoint by John H. Rex

ISSN： 0012-6667

Source： Drugs, Vol.62, Iss.18, 2002-01, pp. : 2665-2666

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pioglitazone: A Viewpoint by John R. Petrie

By Petrie J.R.

Drugs, Vol. 60, Iss. 2, 2000-08 ,pp. : 344-345

Adis International

Access to resources Recommend Favorite

Imatinib: A Viewpoint by John M. Goldman

By Goldman J.M.

Drugs, Vol. 61, Iss. 12, 2001-01 ,pp. : 1775-1776

Adis International

Access to resources Recommend Favorite

Rasagiline: A Viewpoint by Wolfgang H. Oertel

By Oertel Wolfgang H.

Drugs & Aging, Vol. 22, Iss. 1, 2005-01 ,pp. : 93-94

Adis International

Access to resources Recommend Favorite

Telmisartan: A Viewpoint by H.L. Elliott

By Elliott H.L.

Drugs, Vol. 56, Iss. 6, 1998-12 ,pp. : 1045-1046

Adis International

Access to resources Recommend Favorite

Clopidogrel: A Viewpoint by David H. Fitchett

By Fitchett D.H.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 475-475

Adis International

Access to resources Recommend Favorite